Keywords
Immunohaematological profile
Ancestry Informative markers
Mixed population
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate the hematological and lymphocyte profiles of individuals with COVID-19, as well as to identify the ancestral profile through Ancestry Informative Markers from two cities in the Northeast region of Brazil. Methods: Data from 58 individuals with COVID-19 who presented mild (39) and severe (19) clinical conditions were analyzed. The lymphocyte profile was identified by immunophenotyping and genotyping via PCR and qPCR analysis. Data were analyzed by descriptive statistics using IBM SPSS Statistics software. The study was approved by the Research Ethics Committee (ICS-UFBA). Results: Individuals in the severe group showed an increase in total leukocytes and neutrophils, and a decrease in erythrocytes, hemoglobin, hematocrit, and lymphocytes compared to individuals in the mild group. Likewise, the severe group showed a decrease in the cellular profiles of CD4+ T cells, CD8+ T cells, and B lymphocytes. Regarding the ancestral profile, both groups had a greater European ancestral genomic profile. However, the severe group had a higher percentage of African ancestry compared to the mild group. Conclusion: Ancestry was not associated with severity, but the results match findings that individuals' immune responses play a crucial role in COVID-19.
References
ABE-SANDES K, et al. Ancestralidade Genômica, nível socioeconômico e vulnerabilidade ao HIV/aids na Bahia, Brasil. Saúde e Sociedade. 2010; 19: 75–84.
AL-ABDI S e AL-AAMRI M. G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost. Hematology/Oncology and Stem Cell Therapy. 2020; 14(1): 84-85.
AZKUR AK, et al. Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19. Allergy. 2020; 75 (7): 1564–81.
BORGES GM e CRESPO CD. Aspectos demográficos e socioeconômicos dos adultos brasileiros e a COVID-19: uma análise dos grupos de risco a partir da Pesquisa Nacional de Saúde, 2013. Cadernos de SaúdePública. 2020; 36(10): 141020.
CAVALCANTE LN, et al. Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal. World Journal of Hepatology. 2015; 7(10): 1433-1438.
CODD AS, et al. Neutrophilia, lymphopenia and myeloid dysfunction: a living review of the quantitative changes to innate and adaptive immune cells which define COVID-19 pathology. Oxford Open Immunology. 2021; 2(1): 16.
COZIER YC, et al. Lower serum 25(OH)D levels associated with higher risk of COVID-19 infection in U.S. Black women. PLOS ONE. 2021; 16(7): 255132.
DU RH, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. European Respiratory Journal. 2020; 55(5): 2000524.
FARSHBAFNADI M, et al. Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors. Experimental Gerontology. 2021; 154(15): 111507.
FERDINAND K, et al. Contemporary and Future Concepts on Hypertension in African Americans: COVID-19 and Beyond. Journal of the National Medical Association. 2020; 112(3): 315–23.
FERREIRA RBS e CAMARGO CL. Vulnerabilidade da população negra brasileira frente à evolução da pandemia por COVID-19. RevistaCuidarte. 2021; 12(2): 1-12.
FU J, et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thrombosis Research. 2020; 192: 3–8.
GHOBADI H, et al. Role of leukocytes and systemic inflammation indexes (NLR, PLR, MLP, dNLR, NLPR, AISI, SIR-I, and SII) on admission predicts in-hospital mortality in non-elderly and elderly COVID-19 patients. Frontiers in Medicine. 2022; 9: 916453.
HU B, et al. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology. 2020; 20(5): 315.
IBGE. Censo 2010. Govbr 2010. https ://cidades.ibge.gov.br/brasil/ba/salvador/pesquisa/23/25359. Acess: April 2024.
JAIN SK, et al. The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19. Free Radical Biology and Medicine. 2020; 161: 84–91.
JESENAK M, et al. Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis. Frontiers in Cellular and Infection Microbiology. 2020; 10: 364.
JING Y, et al. SARS-CoV-2 infection causes immunodeficiency in recovered patients by downregulating CD19 expression in B cells via enhancing B-cell metabolism. Signal Transduction and Targeted Therapy. 2021; 6(1): 345.
KARIMI SHAHRI M, et al. COVID‐19 and hematology findings based on the current evidences: A puzzle with many missing pieces. International Journal of Laboratory Hematology. 2020; 43(2): 160–8.
MACKEY K, et al. Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths. Annals of Internal Medicine. 2021; 174 (3): 362-373.
MERAD M, et al. The immunology and immunopathology of COVID-19. Science. 2022; 375(6585): 1122–7.
MOSS P. The T cell immune response against SARS-CoV-2. Nature Immunology. 2022; 23(2): 186–93.
MS. MINISTÉRIO DA SAÚDE. Coronavírus Brasil. Covidsaudegovbr 2024. https ://covid.saude.gov.br/ Acess: July, 2024.
NORIN AJ, et al. HLA B53 is associated with a poor outcome in black COVID-19 patients. HumanImmunology. 2021; 82(10): 713-718.
PENA J. Razões para banir o conceito de raça da medicina brasileira. HistoriaCienciasSaude-manguinhos. 2005; 12(2): 321–46.
PENA SDJ, et al. Genetic admixture in Brazil. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2020; 184(4): 928-938.
PRICE-HAYWOOD EG, et al. Hospitalization and Mortality among Black Patients and White Patients with Covid-19. New England Journal of Medicine. 2020; 382(26): 2534-2543.
QUEIROZ EM, et al. Genetic composition of a Brazilian population: the footprint of the Gold Cycle. Geneticsand molecular research: GMR. 2013; 12(4): 5124-5133.
SANTOS MPAD, et al. População negra e Covid-19: reflexões sobre racismo e saúde. EstudosAvançados. 2020; 34(99): 225–44.
SHELTON JF, et al. Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity. Nature Genetics. 2021; 53(6): 801-808.
SHRIVER MD, et al. Ethnic-affiliation estimation by use of population-specific DNA markers. American Journal of Human Genetics. 1997; 60(4): 957–64.
SONG JW, et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nature Communications. 2020; 11(1): 3410.
SUN S, et al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. ClinicaChimicaActa; International Journal of Clinical Chemistry. 2020; 507: 174-180.
TAO Z, et al. Anemia is associated with severe illness in COVID‐19: A retrospective cohort study. Journal of Medical Virology. 2020; 93(3): 1478–88.
TERPOS E, et al. Hematological findings and complications of COVID ‐19. American Journal of Hematology. 2020; 95(7): 834-847.
WANG J, et al. Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19. Frontiers in Immunology. 2020; 11: 2063.
WANG L, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. Journal of Infection. 2020; 80(6): 639-645.
WESTMEIER J, et al. Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patient. mBio. 2020; 11(6): 2805-20.
WOOL GD e MILLER JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2020; 88(1): 1–13.
ZHOU F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395(10229): 1054-1062.